Welcome to our dedicated page for Cbdmd news (Ticker: YCBD), a resource for investors and traders seeking the latest updates and insights on Cbdmd stock.
cbdMD, Inc. (YCBD) provides premium hemp-derived CBD products and functional mushroom supplements through brands like cbdMD, Paw CBD, and ATRx Labs. This news hub offers investors and industry observers centralized access to official updates from this innovative wellness company.
Track all regulatory developments, product launches, and financial disclosures through verified press releases and third-party analysis. Our curated collection helps stakeholders monitor key areas including cannabinoid research advancements, retail distribution expansions, and THC-free product innovations across human and pet wellness markets.
Discover timely updates on earnings reports, manufacturing compliance updates, and strategic partnerships that shape cbdMD's position in the competitive CBD sector. Content is organized for quick scanning while maintaining depth for professional analysis needs.
Bookmark this page for ongoing insights into how YCBD navigates regulatory challenges and capitalizes on emerging trends in functional health. Check regularly for new developments affecting this vertically integrated producer of science-backed wellness solutions.
cbdMD, Inc. (NYSE American: YCBD) has announced that a California class action lawsuit against the company is temporarily stayed. This ruling comes as the judge responded to cbdMD's motion while awaiting the U.S. Food and Drug Administration's guidelines or potential legislation regarding CBD product definitions and marketing. The lawsuit, filed in December 2019, accused cbdMD and others of violating several California laws. The stay closes the case administratively, with parties required to submit status updates every 90 days, starting June 2021.
cbdMD, Inc. (NYSE American: YCBD) recently announced that its cbdMD and Paw CBD product lines received the 2021 Product of the Year awards, marking the first time a CBD brand has won in consecutive years. Selected by 40,000 American consumers through a national survey by Kantar, cbdMD's CBD Gummies were recognized as the most innovative in the CBD Ingestibles category. Paw CBD’s CBD Hard Chews for Dogs also earned the Product of the Year title in the CBD Pet category. This recognition showcases cbdMD's commitment to quality and innovation in the competitive CBD market.
Adara Acquisition Corp. has successfully closed its initial public offering, raising $115 million by selling 11.5 million units at $10 each, including an additional 1.5 million units from an over-allotment option. The units are listed on NYSE American under the ticker symbol 'ADRA.U'. The company, sponsored by cbdMD, Inc. and Blystone & Donaldson, aims to identify potential merger or acquisition targets in the consumer products sector. Each unit includes one share of Class A common stock and half a warrant to purchase additional shares at $11.50 each.
cbdMD, Inc. (NYSE American: YCBD) announced the launch of its Paw CBD pet product line's first national TV advertising campaign during Puppy Bowl XVII on February 7, 2021. This initiative positions Paw CBD as the only featured CBD company in the program, reaching an audience of 2.5 million adults aged 18-49. Paw CBD, known for its THC-free, veterinarian-formulated products, continues to expand its presence in retail, with new agreements with Save Mart Companies adding 100 new locations in California and Nevada. The campaign aims to enhance brand recognition among pet owners.
cbdMD, Inc. (NYSE American: YCBD) reported strong financial results for Q1 FY 2021, with net sales increasing by 22% year-over-year to $12.3 million. Gross profit margin improved to 72.2%, up from 63.5% in the previous quarter. E-commerce sales soared 41% to $9.7 million, and Paw CBD net sales grew by 83% to $1.5 million. Operating expenses decreased by 15% to $10.7 million, while the loss from operations fell 71% to $1.8 million. However, the net loss attributable to shareholders was $9.5 million, primarily due to a non-cash contingent liability related to previous acquisitions.
cbdMD, Inc. (NYSE American: YCBD) has retained Dr. Sibyl Swift, a former FDA official, as a regulatory consultant. Dr. Swift will oversee regulatory initiatives and prepare products for certifications, emphasizing cbdMD's commitment to quality and safety. With a notable background at the FDA and the Natural Products Association, Dr. Swift's expertise aims to enhance cbdMD's compliance and product standards. The move signifies cbdMD's strategy to align with regulatory requirements and strengthen market position in the CBD industry.
cbdMD, Inc. (NYSE American: YCBD) announced a conference call scheduled for February 9, 2021, at 4:15 p.m. ET to discuss its Q1 2021 financial results and business updates. Investors can join the call using domestic dial-in number 1-888-267-2822 or international number 1-973-528-0011. A replay will be available through March 11, 2021 using the passcode 39768. The company is recognized for its extensive line of THC-free CBD products, available through various retail outlets and online.
cbdMD announced a renewed sponsorship with rally driver Ken Block, enhancing brand visibility in his racing events. Block will display the cbdMD logo on his fire suit and rally car while promoting the brand through various marketing initiatives. He expressed confidence in cbdMD products, integrating them into his health regimen and opting for part of his sponsorship in the company's stock. cbdMD aims to leverage Block's 8 million social media followers to boost awareness of its CBD offerings for athletes and everyday users.
cbdMD, Inc. (NYSE American: YCBD, YCBDpA) has launched a new beauty and skincare line called cbdMD Botanicals, featuring 15 luxury products. The line aims to combine cbdMD’s patented CBD formula with all-natural ingredients, promoting a vegan and gluten-free approach. Products range from facial oils and serums to moisturizers and masks. The launch is poised to position cbdMD in the expanding global beauty and skincare market, aiming to meet consumer demand for natural, high-quality options.
